(<i>S</i>)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1<i>H</i>,13<i>H</i>-dibenzo[<i>e</i>,<i>k</i>]pyrrolo[3,4-<i>h</i>][1,4,13]oxadiazacyclohexadecene-1,3(2<i>H</i>)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ

DOI Web Site 1 Citations
  • Michael R. Jirousek
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • James R. Gillig
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Cecile M. Gonzalez
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • William F. Heath
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • John H. McDonald
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • David A. Neel
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Christopher J. Rito
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Upinder Singh
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Lawrence E. Stramm
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Anita Melikian-Badalian
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Matthew Baevsky
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Lawrence M. Ballas
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Steven E. Hall
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Leonard L. Winneroski
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221
  • Margaret M. Faul
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, Sphinx Pharmaceutical Corporation, Durham, North Carolina 27712, and Lilly Chemical Process Research and Development, Eli Lilly and Company, Indianapolis, Indiana 46221

Bibliographic Information

Published
1996-01-01
DOI
  • 10.1021/jm950588y
Publisher
American Chemical Society (ACS)

Search this article

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top